Cargando…
Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells
Chemoresistance is a major obstacle in chemotherapy of laryngeal carcinoma. Recently, studies indicate that cancer stem cells are responsible for chemotherapy failure. In addition, microRNAs play important roles in tumor initiation, development and multidrug resistance. In the present study, we foun...
Autores principales: | Liu, Jiajia, Tang, Qinglai, Li, Shisheng, Yang, Xinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349925/ https://www.ncbi.nlm.nih.gov/pubmed/27880721 http://dx.doi.org/10.18632/oncotarget.13424 |
Ejemplares similares
-
miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1
por: Hu, Guinv, et al.
Publicado: (2018) -
lncRNA‐NKILA/NF‐κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance
por: Yang, Tao, et al.
Publicado: (2018) -
Obstructive sleep apnea in patients with laryngeal cancer after supracricoid or vertical partial laryngectomy
por: Ouyang, Lei, et al.
Publicado: (2019) -
miR-654-5p Targets HAX-1 to Regulate the Malignancy Behaviors of Colorectal Cancer Cells
por: Huang, Fuda, et al.
Publicado: (2020) -
Long chain noncoding RNA-ROR promotes hypoxic injury of cardiomyocytes by targeting the miR-145/HAX-1 axis
por: Yang, Ya, et al.
Publicado: (2022)